Back to BIIB Stock Lookup

BIIB Related

May 23, 2013 10:44 AM Vivus (VVUS) Sees Upside on Icahn Connection

May 23, 2013 08:20 AM Biogen Idec (BIIB) Appoints Spyros Artavanis-Tsakonas as CSO

May 23, 2013 08:00 AM Biogen Idec Appoints Spyros Artavanis-Tsakonas Chief Scientific Officer

May 22, 2013 04:01 PM Biogen Idec to Present at the Deutsche Bank 38th Annual dbAccess Healthcare Conference

May 21, 2013 05:00 AM RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market

May 21, 2013 04:30 AM Biogen Idec Submits Application to FDA for Approval of PLEGRIDY™ (Peginterferon Beta-1a) in Multiple Sclerosis

May 20, 2013 04:43 PM Biogen's (BIIB) BG-12 Data Not Inflated

May 20, 2013 10:06 AM Biogen (BIIB) Weeks-6 TECFIDERA Scripts Continue to Ramp

May 13, 2013 09:41 AM Biogen's (BIIB) TECFIDERA Scripts Accelerating WoW

May 13, 2013 09:31 AM StreetInsider.com Pre-Open Movers 5/13: (THRX) (MTSN) (TSLA) Higher; (AFFY) (CEL) (UNXL) Lower (more...)

May 13, 2013 07:31 AM Biogen (BIIB) BLA for ELOCTATE Accepted by FDA

May 13, 2013 07:30 AM FDA Accepts Biogen Idec’s Biologics License Application for First Long-Lasting Factor VIII Therapy for Hemophilia A

May 13, 2013 05:00 AM RBCC Partner n3D Signs U.S. Distribution Agreement

May 7, 2013 01:37 PM Form 4 BIOGEN IDEC INC. For: May 03 Filed by: Pawlicki Raymond

May 7, 2013 01:34 PM Form 4 BIOGEN IDEC INC. For: May 03 Filed by: Cox John

May 6, 2013 08:40 AM Scripts Data Indicates Biogen's (BIIB) Tecfidera Could Beat 2013 Estimates by $400M

May 6, 2013 05:00 AM World’s Premiere Science Journal Touts Revolutionary Innovations by RBCC Partner Nano3D

May 3, 2013 03:10 PM Form 4 BIOGEN IDEC INC. For: May 01 Filed by: COVINO GREGORY F

May 3, 2013 03:08 PM Form 4 BIOGEN IDEC INC. For: May 01 Filed by: SCANGOS GEORGE A

May 1, 2013 03:45 PM Form 4 BIOGEN IDEC INC. For: Apr 29 Filed by: Clancy Paul J

May 1, 2013 09:35 AM StreetInsider.com Pre-Open Movers 5/1: (IQNT) (MSPD) (RATE) Higher; (HIMX) (MELA) (MRK) Lower (more...)

May 1, 2013 07:20 AM Goldman Sachs Downgrades Biogen (BIIB) to Neutral, Removes from CL List

May 1, 2013 06:45 AM Goldman Sachs Upgrades Amgen (AMGN) to Conviction Buy

Apr 30, 2013 05:00 AM RBCC: Personalized Medicine Poised to Revolutionize Insurance & Pharmaceuticals

Apr 29, 2013 12:53 PM Deutsche Bank Sees Upside for Biogen's (BIIB) Tecfidera

Apr 29, 2013 10:10 AM Biogen Idec (BIIB) Pops on Strong Tecfidera Rx Growth

Apr 26, 2013 08:03 AM Jefferies Lifts Numbers on Biogen (BIIB) Post Q1

Apr 25, 2013 04:02 PM Form 10-Q BIOGEN IDEC INC. For: Mar 31

Apr 25, 2013 02:00 PM Deutsche Bank Maintains Buy on Biogen (BIIB)

Apr 25, 2013 09:35 AM StreetInsider.com Pre-Open Movers 4/25: (AKAM) (INFN) (FIO) Higher; (XIDE) (INTU) (CTXS) Lower (more...)

Apr 25, 2013 07:27 AM Form 8-K BIOGEN IDEC INC. For: Apr 25

Apr 25, 2013 06:31 AM Biogen Idec, Inc. (BIIB) Tops Q1 EPS by 34c; Boosts FY13 Outlook

Apr 25, 2013 06:30 AM Biogen Idec Total Revenues Increased 10% to $1.4 Billion in First Quarter 2013

Apr 24, 2013 05:33 PM Trading Radar for 04/25: Exxon, (XOM), Dow (DOW), 3M (MMM), Hershey (HSY), UPS (UPS), Expedia (EXPE) Report

Apr 24, 2013 05:00 AM RBCC Looks Overseas for Potentially Lucrative Licensing Opportunities

Apr 22, 2013 05:24 PM Deutsche Bank Raises Biogen (BIIB) Price Target to $240

Apr 22, 2013 02:55 PM Notable 52-Week Highs and Lows of the Day 04/22: (HAS) (CELG) (RAD) High; (MHR) (BTU) Low

Apr 22, 2013 12:59 PM Strong Biogen (BIIB) Tecfideara Sales Tied to Patient 'Warehousing'

Apr 22, 2013 08:48 AM Early Data Says Biogen's (BIIB) Tecfidera Doing Well - Analyst

Apr 16, 2013 12:50 PM UPDATE: Glaxo (GSK) wins appeals court ruling over Biogen Idec (BIIB) cancer patent

Apr 15, 2013 04:28 AM RBCC Nears Deal With Leading Genetic Testing Lab

Apr 12, 2013 09:00 AM BofA/Merrill Lynch Upgrades Biogen (BIIB) to Buy

Apr 10, 2013 04:01 PM Biogen Idec to Report First Quarter 2013 Financial Results on April 25, 2013

Apr 9, 2013 07:11 AM RBC Capital Raises PT on Biogen (BIIB) to $215

Apr 4, 2013 08:15 AM The Lancet Publishes SELECT Study Evaluating Efficacy and Safety of Daclizumab HYP in Multiple Sclerosis

Apr 2, 2013 04:54 PM Form 8-K BIOGEN IDEC INC. For: Apr 02

Apr 2, 2013 04:30 PM Biogen Idec Completes Purchase of Full Rights and Control of TYSABRI®

Apr 2, 2013 01:23 PM Form 4 BIOGEN IDEC INC. For: Apr 01 Filed by: SCANGOS GEORGE A

Apr 2, 2013 05:26 AM RBCC: New Rainbow BioSciences Website Highlights Impressive Deal Flow

Mar 28, 2013 04:45 PM Top 10 News Items for 03/25 - 03/28: S&P 500 Hits New Record High; Q4 U.S. GDP Growth Ebbs; Investors Flock Dell

Back to BIIB Stock Lookup